Tavaborole
Back to searchMolecule Structure
Scientific Name
Tavaborole
Description of the Drug
Tavaborole is an antifungal agent used to treat onychomycosis, a fungal infection of the nail.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09041
http://www.drugbank.ca/drugs/DB09041
Brand Name(s)
Kerydin
Company Owner(s)
Cipla Ltd, Padagis Us Llc, Anacor Pharmaceuticals Inc, Aleor Dermaceuticals Ltd, Chartwell Rx Sciences Llc, Encube Ethicals Private Ltd, Amneal Pharmaceuticals Llc, Taro Pharmaceuticals Inc, Lupin Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Leucine-tRNA ligase | SINGLE PROTEIN | INHIBITOR | CHEMBL3307222 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL500016 | |
DrugBank | DB09041 | |
PubChem: Thomson Pharma | 16601086 | |
PubChem | 11499245 | |
Nikkaji | J2.495.581H | |
BindingDB | 50370987 | |
EPA CompTox Dashboard | DTXSID00169888 | |
DrugCentral | 4877 | |
Brenda | 59010 | 78416 |
ChemicalBook | CB42454906 | |
rxnorm | TAVABOROLE | KERYDIN |
PubChem: Drugs of the Future | 22395917 | |
ChEBI | 77942 | |
ZINC | ZINC000169990691 |